Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Looking for a particular Celldex Therapeutics employee's phone or email?
The Celldex Therapeutics annual revenue was $9 million in 2026.
Anthony Marucci is the President and CEO of Celldex Therapeutics.
186 people are employed at Celldex Therapeutics.
Celldex Therapeutics is based in Hampton, New Jersey.
The NAICS codes for Celldex Therapeutics are [3254, 325, 32541, 32].
The SIC codes for Celldex Therapeutics are [283, 28].